Authorities in China have ordered an emergency recall of more than 12,000 units of a blood plasma product, potentially the latest scandal to undermine public trust in the nation’s health care system.
from NYT > Health https://nyti.ms/2GdkaEa
from NYT > Health https://nyti.ms/2GdkaEa